Homepage
Education
Explore the intricate landscape of benzodiazepine treatment for anxiety disorders, providing clinicians with essential insights to optimize patient care. Participants will evaluate the nuanced risk-benefit profile of benzodiazepines as a first-line therapy, considering effectiveness, side effects, and long-term outcomes.
News
Antidepressant prescribing patterns and outcomes for patients with major depressive disorder (MDD) vary significantly between prescriber groups, suggest study findings published in JAMA Psychiatry.
Pneumonia in patients with schizophrenia is associated with the use of specific antipsychotics, according to study findings published in JAMA Psychiatry.
Patients with tardive dyskinesia (TD) in long-term care (LTC) settings have a high comorbidity and polypharmacy burden, with almost half taking medications that can actually worsen TD
Long-term anticholinergic medication exposure can cause long-term consequences that surpass previously documented short-term cognitive effects, according to a review recently published in the Journal of Neurochemistry.
Videos
Posters
It is essential to predict the side effects of concomitant drug use before their clinical complications. To streamline drug prescriptions, we developed a machine-learning pipeline to calibrate the severity of DDIs tailored to psychiatric patients.
The Pathway Platform was designed to improve measurement-based care (MBC) and shared decision-making among patients with major depressive disorder (MDD) and primary care providers (PCPs).
Review of the pharmacology, indications, and safety/tolerability profiles of existing opioid antagonists.